| 2026-05-28 |
详情>>
内部人交易：
Mulligan Seamus等共交易4笔
|
| 2026-05-05 |
详情>>
股本变动：
变动后总股本6274.28万股
|
| 2026-05-05 |
详情>>
业绩披露：
2026年一季报每股收益4.73美元,归母净利润2.93亿美元,同比去年增长416.72%
|
| 2026-05-05 |
财报披露：
美东时间 2026-05-05 盘后发布财报
|
| 2026-02-24 |
详情>>
业绩披露：
2025年年报每股收益-5.84美元,归母净利润-3.56亿美元,同比去年增长-163.58%
|
| 2026-02-24 |
详情>>
业绩披露：
2023年年报每股收益6.55美元,归母净利润4.15亿美元,同比去年增长285.14%
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-9.18美元,归母净利润-5.6亿美元,同比去年增长-251.65%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益-13.28美元,归母净利润-8.11亿美元,同比去年增长-626.8%
|
| 2025-06-06 |
股东大会：
将于2025-07-24召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in our accompanying proxy statement to hold office until the 2028 annual meeting of shareholders.
2.To ratify, on a non-binding advisory basis, the appointment of KPMG as our independent auditors for the fiscal year ending December 31, 2025 and to authorize, in a binding vote, our board of directors, acting through our audit committee, to determine the independent auditors’ remuneration.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers.
4.As a special resolution, to grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply.
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-1.52美元,归母净利润-9254.1万美元,同比去年增长-533.06%
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益-3.58美元,归母净利润-2.24亿美元,同比去年增长32.03%
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益9.06美元,归母净利润5.60亿美元,同比去年增长35.02%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益5.93美元,归母净利润3.69亿美元,同比去年增长15.07%
|
| 2024-08-01 |
详情>>
业绩披露：
2024年中报每股收益2.45美元,归母净利润1.54亿美元,同比去年增长-11.45%
|
| 2024-06-14 |
股东大会：
将于2024-07-25召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2027 annual meeting of shareholders.
2.To ratify, on a non-binding advisory basis, the appointment of KPMG as our independent auditors for the fiscal year ending December 31, 2024 and to authorize, in a binding vote, our board of directors, acting through our audit committee, to determine the independent auditors’ remuneration.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers, or NEOs, as disclosed in the accompanying proxy statement.
4.To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of our named executive officers.
5.To grant our board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply.
6.To approve any motion to adjourn the annual meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve Proposal 5.
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.23美元,归母净利润-1461.8万美元,同比去年增长-121.06%
|
| 2023-06-16 |
股东大会：
将于2023-08-03召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2026 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of the company for the fiscal year ending December 31, 2023 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers, or NEOs, as disclosed in the accompanying proxy statement (Proposal 3).
4.To grant the board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply (Proposal 4).
5.To approve any motion to adjourn the annual meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve Proposal 4 (Proposal 5).
|
| 2022-06-13 |
股东大会：
将于2022-07-28召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2025 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin, or KPMG, as the independent auditors of the company for the fiscal year ending December 31, 2022 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers, or NEOs, as disclosed in the accompanying proxy statement (Proposal 3).
4.To grant the board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply (Proposal 4).
5.To approve any motion to adjourn the annual meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve Proposal 4 (Proposal 5).
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-30 |
股东大会：
将于2021-09-23召开股东大会
会议内容 ▼▲
- 1.To grant the board of directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply (Proposal 1).
2.To approve any motion to adjourn the EGM, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the EGM to approve Proposal 1 (Proposal 2).
|
| 2021-06-11 |
股东大会：
将于2021-07-29召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2024 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin, or KPMG, as the independent auditors of the company for the fiscal year ending December 31, 2021 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers, or NEOs, as disclosed in the accompanying proxy statement (Proposal 3).
4.To renew the board of directors’ existing authority under Irish law to allot and issue ordinary shares (Proposal 4).
5.To renew the board of directors’ existing authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply (Proposal 5).
6.To approve any motion to adjourn the annual meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve Proposal 5 (Proposal 6).
|
| 2020-06-12 |
股东大会：
将于2020-07-30召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2023 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin, or KPMG, as the independent auditors of the company for the fiscal year ending December 31, 2020 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers, or NEOs, as disclosed in the accompanying proxy statement (Proposal 3).
4.To approve an amendment and restatement of the company’s Amended and Restated 2007 Non-Employee Directors Stock Award Plan (the “Directors Plan”) in order to, among other things, increase the number of ordinary shares authorized for issuance under the Directors Plan by 500,000 shares (Proposal 4).
5.To approve a capital reduction and creation of distributable reserves under Irish law (Proposal 5). To conduct any other business properly brought before the annual meeting.
|
| 2019-06-14 |
股东大会：
将于2019-08-01召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions each of the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2022 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin, or KPMG, as the independent auditors of the company for the fiscal year ending December 31, 2019 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers, or NEOs, as disclosed in the accompanying proxy statement (Proposal 3).
4.To conduct any other business properly brought before the annual meeting.
|
| 2018-06-15 |
股东大会：
将于2018-08-02召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions the four named nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2021 annual meeting of shareholders (Proposal 1).
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as the independent auditors of the company for the fiscal year ending December 31, 2018 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers as disclosed in the accompanying proxy statement (Proposal 3).
4.To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of the company’s named executive officers (Proposal 4).
5.To conduct any other business properly brought before the annual meeting.
|
| 2017-06-20 |
股东大会：
将于2017-08-03召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions the three nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2020 annual meeting of shareholders.
2.To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as the independent auditors of the company for the fiscal year ending December 31, 2017 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration.
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers as disclosed in the accompanying proxy statement.
4.To authorize the company and/or any subsidiary of the company to make open market purchases of the company’s ordinary shares.
5.To conduct any other business properly brought before the annual meeting.
|
| 2016-06-20 |
股东大会：
将于2016-08-04召开股东大会
会议内容 ▼▲
- 1. To elect by separate resolutions the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2019 annual general meeting of shareholders (Proposal 1).
2. To ratify, on a non-binding advisory basis, the appointment of KPMG, Dublin as the independent auditors of the company for the fiscal year ending December 31, 2016 and to authorize, in a binding vote, the board of directors, acting through the audit committee, to determine the independent auditors’ remuneration (Proposal 2).
3. To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers as disclosed in the accompanying proxy statement (Proposal 3).
4A. To approve amendments to the company’s memorandum of association to make certain administrative adjustments to address the enactment of the Irish Companies Act 2014 and a minor housekeeping matter (Proposal 4A).
4B. To approve amendments to the company’s articles of association to make certain administrative adjustments to address the enactment of the Irish Companies Act 2014 and certain minor housekeeping matters (Proposal 4B).
5. To authorize the company and/or any subsidiary of the company to make open market purchases of the company’s ordinary shares (Proposal 5).
6. To renew the board of directors’ existing authority under Irish law to allot and issue ordinary shares (Proposal 6).
7. To renew the board of directors’ existing authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre-emption right that would otherwise apply (Proposal 7).
8. To approve any motion to adjourn the annual meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the annual meeting to approve any or all of Proposals 4A, 4B and/or 7 (Proposal 8).
9. To approve an amendment and restatement of the company’s 2011 Equity Incentive Plan in order to renew the company’s ability to grant awards thereunder that may qualify as “performance-based compensation” under section 162(m) of the U.S. Internal Revenue Code (Proposal 9).
10. To approve an amendment and restatement of the company’s Amended and Restated 2007 Non-Employee Directors Stock Option Plan in order to (i) expand the types of stock awards that may be granted thereunder to the company’s non-employee directors and (ii) eliminate the final automatic annual increase to the share reserve that otherwise is scheduled to occur in 2017 pursuant to the “evergreen” provision included therein (Proposal 10).
11. To conduct any other business properly brought before the annual meeting.
|
| 2015-06-10 |
股东大会：
将于2015-07-30召开股东大会
会议内容 ▼▲
- 1.To elect by separate resolutions the four nominees for director named in the accompanying proxy statement (the “proxy statement”) to hold office until the 2018 annual general meeting of shareholders.
2.To approve the appointment of KPMG as the independent auditors of the company for the fiscal year ending December 31, 2015 and to authorize the board of directors, acting through the audit committee, to determine the auditors’ remuneration.
3.To authorize the company and/or any subsidiary of the company to make market purchases of the company’s ordinary shares.
4.To approve, on an advisory basis, the compensation of the company’s named executive officers as disclosed in the accompanying proxy statement.
5.To receive and consider the company’s Irish statutory accounts for the fiscal year ended December 31, 2014 and the reports of the directors and auditors thereon, and to review the affairs of the company.
6.To conduct any other business properly brought before the annual meeting.
|
| 2012-06-20 |
复牌提示：
2012-01-18 07:00:01 停牌，复牌日期 2012-01-18 08:50:00
|